| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SNX-2112:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.065 | 0.04 |
| mRNA | Genentech Cpd 10 | GDSC1000 | pan-cancer | AAC | -0.061 | 0.04 |
| mRNA | etomoxir | CTRPv2 | pan-cancer | AAC | -0.075 | 0.04 |
| mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.075 | 0.05 |
| mRNA | HBX-41108 | CTRPv2 | pan-cancer | AAC | 0.084 | 0.05 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | 0.061 | 0.05 |
| mRNA | KU 0060648 | CTRPv2 | pan-cancer | AAC | 0.07 | 0.05 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | GSK-650394 | GDSC1000 | pan-cancer | AAC | -0.069 | 0.05 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.05 |